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Abstract:  The International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global
framework for training future toxicologic pathologists who will support regulatory-type nonclinical toxicology studies.
Trainees optimally should undertake a scientific curriculum of at least 5 years at an accredited institution leading to a
clinical degree (veterinary medicine or medicine).  Trainees should then obtain 4 or more years of intensive pathology
practice during a residency and/or on-the-job “apprenticeship,” at least 2 years of which must be focused on regulatory-
type toxicologic pathology topics.  Possession of a recognized pathology qualification (i.e., certification) is highly
recommended.  A non-clinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if
medically trained pathologists are scarce, but this option is not optimal.  Regular, lifelong continuing education (peer
review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance
one’s understanding of current toxicologic pathology knowledge, skills, and tools.  This framework should provide a
rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and
communicate data in regulatory-type, nonclinical toxicology studies.  (J Toxicol Pathol 2010; 23: 171–181)
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Introduction
Defining the optimal range of training activities should
increase the consistency with which individuals are educated
in regulatory-type toxicologic pathology across various geo-
graphic regions even in the absence of a uniform global rec-
ognition system.  Such a framework must acknowledge the
diverse educational opportunities, on-the-job training activi-
ties, cultural mores, institutional and societal expectations,
and roles for toxicologic pathologists around the world.
Nevertheless, the framework should represent a high bar for
professional practice that will be applicable to toxicologic
pathologists in both developed nations (i.e., those with long-
established conventions for conducting the pathology analy-
ses of regulatory-type, nonclinical toxicity studies, and for
training the individuals who fulfill this role) and emerging
nations (i.e., those in which such pathology practices and
training programs have yet to be fully formalized).
A reasonable approach to developing a workable global
framework of training activities is to propose “best prac-
tices” to impart the core theoretical knowledge and applied
skills that are essential prerequisites for pathologists who
participate in regulatory-type, nonclinical toxicity studies.
Topics that must be addressed when formulating such a pro-
posal can be summarized in five basic questions.
1. What roles do regulatory-type toxicologic pathologists
serve?
2. What are the core knowledge and practical work-
related skills required to function as a regulatory-type
toxicologic pathologist?
3. What are suitable educational approaches for impart-
ing core knowledge to regulatory-type toxicologic
pathologists?
4. What experiences are most suitable for acquiring prac-
tical work-related skills in regulatory-type toxicologic
pathology?
5. How much training do regulatory-type toxicologic
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pathologists require?
A committee of toxicologic pathologists with substan-
tial experience in performing regulatory-type nonclinical
toxicology studies, representing all ten IFSTP member soci-
eties, was assembled (Table 1) to answer these questions and
produce the present international proposal for training regu-
latory-type toxicologic pathologists.  Given the variability in
current training approaches across regions, this document
will identify optimal (“best”) practices while acknowledging
alternative routes that might be suitable under certain cir-
cumstances.
1. What roles do regulatory-type toxicologic pathologists
serve?
Toxicologic pathologists contributing to regulatory-
type, nonclinical toxicity studies are typically engaged in
generating, interpreting, and communicating anatomic
pathology data (e.g., organ weights, macroscopic and micro-
scopic examination of tissues) OR clinical pathology data
(clinical chemistry, hematology, coagulation, urinalysis,
flow cytometry, biomarker validation, etc.) OR both ana-
tomic pathology and clinical pathology data.  The choice of
role depends on individual, institutional, and societal prefer-
ences.  For example, clinical pathology specialists are rou-
tinely engaged full-time in support of regulatory-type
nonclinical toxicity studies in North Americaa 1 and Europe,
while clinical pathologists are not utilized in this capacity in
Japan.  Regardless of their role, individual toxicologic
pathologists accept responsibility for the integrity and reli-
ability of their work and affirm the validity of their contribu-
tions by signing the pathology reports that they produce.
Single-author pathology reports are acceptable if the toxico-
logic pathologist has been trained to integrate anatomic
pathology and clinical pathology findings; this model com-
prises the traditional “study pathologist” role found in many
regions of the world.  Alternatively, an anatomic pathologist
may interpret anatomic pathology data and a clinical pathol-
ogist may interpret clinical pathology data within separate or
combined pathology reports, with each specialist signing a
report reflecting his or her contributions.  This multi-partici-
pant model of integrating pathology data is common in many
institutions with the means to build such expert teams.
Wide-ranging command of basic and applied scientific
and medical knowledge coupled with substantial practice in
a broad array of essential pathology skills is the foundation
for proficiency in toxicologic pathology, regardless of any
subsequent individual choice to concentrate one’s academic
and work-related experiences to a specific toxicologic
pathology role.  Therefore, the means by which toxicologic
pathologists acquire their particular knowledge, skills, and
practical experience should be qualitatively similar for regu-
latory-type toxicologic pathologists throughout the world.
National or regional differences in societal expectations, cul-
tural mores, and training resources would then serve to mod-
ify the quantitative nature of the toxicologic pathology
training experience (e.g., how much time is spent in ana-
tomic pathology vs. clinical pathology functions), as long as
the overall quality of the program and its final product—tox-
icologic pathologists capable of performing in the role that
they fill—are always maintained.
2. What are the core knowledge and practical work-
related skills required to function as a regulatory-type
toxicologic pathologist?
A pathologist is a biomedical scientist with extensive
clinical training (e.g., in veterinary medicine or medicine) as a More than 30 individuals fulfill this function.
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well as a thorough understanding of normal biological struc-
tures (tissues and fluids) and functions as well as their pertur-
bations resulting from disease.  Proficiency as a pathologist
requires comprehension at multiple levels of biological orga-
nization (e.g., whole animal, cellular, molecular), and the
ability to integrate this information with fundamental medi-
cal principles to formulate differential diagnoses as well as
to identify and characterize disease etiologies and mecha-
nisms (Scudamore and Smith, 2007).
Acceptable performance as a regulatory-type toxico-
logic pathologist requires that an individual have a solid back-
ground in the comparative aspects of normal anatomy (at the
gross and light microscopic levels), physiology, and medicine
of animals and humans; causes and mechanisms of major
background and xenobiotic-induced diseases of common lab-
oratory animal species and humans; principal techniques rou-
tinely used for evaluating pathologic changes in tissues (e.g.,
gross dissection, light microscopy, routine histochemistry
and immunocytochemistry) and body fluids (clinical chemis-
try, cytology, hematology, urinalysis, etc.); and essential prin-
ciples, practices, and regulations applicable to risk and safety
assessment.  Such knowledge is necessary for the practice of
regulatory-type toxicologic pathology regardless of whether
an individual engages primarily in tissue analysis (i.e., ana-
tomic pathology), cell and fluid assessment (i.e., clinical
pathology), or some combination of the two.
Other skills and knowledge will obviously be important
for toxicologic pathologists in the 21st century.  Examples of
specific skills include ultrastructural analysis (mainly trans-
mission electron microscopy), innovative microscopy tech-
niques (confocal, fluorescence, etc.), morphometry, and
stereology.  Toxicologic pathologists should also have at
least some familiarity with contemporary research tools,
especially such molecular methods as in situ hybridization
and laser capture microdissection, and evolving scientific
disciplines (genomics, metabolomics, proteomics, toxicoge-
nomics, etc.).  Many regulatory-type, nonclinical studies will
not utilize these advanced skills and knowledge, and the tox-
icologic pathologists assigned to such projects thus may not
need training in these topics.  However, if a regulatory-type,
nonclinical toxicity study does employ such sophisticated
skills and knowledge, then the toxicologic pathologist cho-
sen for the study clearly must be appropriately trained to
interpret the resulting data set.
3. What are suitable educational approaches for impart-
ing core knowledge to regulatory-type toxicologic pathol-
ogists?
Substantial challenges were encountered in formulating
flexible but rigorous “universal” training practices for toxi-
cologic pathologists.  The two main obstacles were the mul-
tiplicity of educational approaches that have been employed
historically in various regions of the world and the lack of
common training standards for presumably equivalent pro-
fessional degrees among countries (e.g., veterinary medical
training in China [4 or 5 years leading to a bachelor’s
degree2] vs. the United States [6 to 8 years leading to a doc-
toral degree;3), or even within a country (e.g., traditional
advanced pathology instruction leading to a graduate degree
vs. a new certifying examination4).  Nevertheless, a work-
able common framework for training regulatory-type toxico-
logic pathologists may be readily defined within the
educational systems that have been developed in geographic
regions with well-established conventions for conducting
regulatory-type, nonclinical toxicity studies.
The baseline education for toxicologic pathologists
includes the foundational sciences listed in Table 2.  Toxico-
logic pathologists must integrate fundamental knowledge
from many basic science disciplines with core clinical con-
cepts and mechanisms, and do so across multiple species.
The optimal practice for training toxicologic pathologists in
the future will be successful completion of a clinical degree
in veterinary medicine (e.g., BVSc, DVM, or the equivalent,
emphasizing allopathic [Western] principles of practice)
from an accreditedb university or college, followed by addi-
tional post-graduate training in pathology.  The logic for this
approach is that individuals with this background will have
acquired their core medical knowledge and toxicologic
pathology training in the animal species utilized most com-
monly for regulatory-type, nonclinical toxicity studies.  Nat-
urally, veterinary pathologists should also study human
anatomy, physiology, and pathology so that their interpreta-
tions of animal findings in nonclinical toxicity studies may
be applied in a public health context.  The reason for advo-
cating that academic institutions be accredited is that this sta-
tus provides a minimum level of assurance that appropriate
training has been offered by acceptably capable teachers.
In some geographic regions, regulatory-type toxico-
logic pathologists have been trained historically using alter-
native educational pathways.  One approach has been to
employ medical pathologists (rather than veterinary patholo-
gists).  Similar to their veterinary counterparts, medical
pathologists seeking careers in toxicologic pathology will
have successfully finished a clinical degree (e.g., MD or the
equivalent) from an accredited educational institution fol-
lowed by advanced post-graduate training in pathology.
However, medical pathologists functioning as toxicologic
pathologists for regulatory-type, nonclinical toxicity studies
also will need to complete several comparative biology
courses (including anatomy, physiology, and pathology)
during their post-graduate training to compensate for the
absence of such animal-oriented material during their
human-oriented clinical curriculum.  Another alternative
approach has been to co-opt medical biologists with doc-
toral-level training in a relevant biological field (e.g., pathol-
ogy, pharmacology, or toxicology) as regulatory-type
toxicologic pathologists due to the scarcity of veterinary
pathologists and medical pathologists.  As with any activity,
medical biologists may improve their toxicologic pathology
talents by practice.  However, acceptable performance of
medical biologists in this role generally requires an emphasis
in their academic curriculum on core subjects in medicine,
b By a national organization.Proposed Training for Future Toxicologic Pathologists 175
pathology, and toxicology as well as an integrative (e.g.,
“whole animal”) focus to biological investigation rather than
mainly cellular or molecular approaches used in mechanistic
research, as well as extended periods of intensive on-the-job
instruction to compensate for the absence of a rigorous edu-
cation in clinical medicine.
Persons who lack a clinical (veterinary medical or med-
ical) degree and post-graduate academic training in pathol-
ogy or a doctoral-level degree in a pathology-related
biomedical discipline are unlikely to possess sufficient com-
mand of the core theoretical knowledge required of regula-
tory-type toxicologic pathologists.
4. What experiences are most suitable for acquiring
practical work-related skills in regulatory-type toxico-
logic pathology?
The applied work-related skills and tools required of
regulatory-type toxicologic pathologists are listed in Table 3.
These elements may be introduced during academic course-
work (in laboratory sessions rather than reading assign-
ments).  However, the limited experience available in such
educational settings necessitates that more extensive practice
be gained elsewhere for real aptitude to be developed5.
Accordingly, the optimal way to obtain sufficient practical
experience as a regulatory-type toxicologic pathologist is via
intensive post-graduate training that focuses on generation
and interpretation of pathology data.  The rationale for this
recommendation is that persons with wide-ranging practice
using basic pathology skills and tools are much more likely
to quickly and easily develop proficiency as toxicologic
pathologists.
Initial practical training in pathology should include
ample diagnostic work in anatomic pathology or clinical
pathology (or both), some or all of which should involve
problems with natural or experimental cases of toxicity.
Training in anatomic pathology and clinical pathology skills
and tools is typically initiated in an academic setting during
the classroom and clinical rotations of a veterinary medical
(or medical) course.  In some nations, these basic lessons are
then refined during an academic residency in pathology.
Such residencies usually emphasize the skills and tools of a
particular pathology specialty (e.g., anatomic pathology OR
clinical pathology), often as applied to diagnostic cases in a
hospital setting.  However, optimal residency training will
include an absolute requirement that time be spent learning
skills relevant to toxicologic pathology (e.g., trainees with
educational support from the ACVP/STP Coalition for Vet-
erinary Pathology Fellows) and will generally offer at least
some cross-training in both anatomic pathology and clinical
pathology.  Research training in pathology (as a MS or PhD
[or equivalent] student, or as a post-residency clinical fellow
in veterinary medicine or medicine) often serves as a useful
Table 2. International Recommendations for Core Subjects to be Included in Training
Programs for Regulatory-Type Toxicologic Pathologists
Required of all pathologists Recommended for toxicologic pathologists
Anatomy Anatomy, Comparative*
Biochemistry Pathology, Comparative*
Biology Pathology, Laboratory Animal*
Cell Biology Pharmacology
Chemistry Physiology, Comparative*
Clinical Chemistry Toxicology
Embryology General 
Experimental Design Systemic (organ-based) 
Hematology Species-specific* 
Histology Toxicodynamics
Immunology Toxicokinetics
Internal Medicine (veterinary or human) Statistical Analysis
Microbiology Toxicologic Pathology*
Bacteriology
Parasitology
Virology
Pathology
General
Systemic (organ-based)
Species-specific
Anatomic
Clinical
Physiology
Toxicologic pathology trainees must have classes and/or appropriate laboratory or on-the-job
experiences in the topics listed above some time during their clinical training (in veterinary
medicine or medicine) or post-graduate program in pathology.  Topics that are often fulfilled by
suitable on-the-job supplemental courses and/or experience are denoted by an asterisk (*).176 Proposed Training for Future Toxicologic Pathologists
supplement to such applied programs as some important
concepts (e.g., study design, statistical analysis) represent a
small portion of the curriculum in many conventional clini-
cally-oriented pathology residencies.  However, research
training alone is not a suitable substitute for adequate practi-
cal experience in pathology.
Applied skills and tools in regulatory-type toxicologic
pathology are often gained during an on-the-job apprentice-
ship (formal or informal) sponsored by one’s first employer.
In most countries such experience occurs (1) following a
clinical degree in veterinary medicine or medicine or (2) fol-
lowing both a clinical degree and an academic pathology res-
idency.  Such apprenticeships tend to stress training in the
tasks associated with only one pathology specialty (often
anatomic pathology for traditional “study pathologists” in
many regions of the world).  The main advantage of this
arrangement is that “apprentice” toxicologic pathologists are
immersed in problems of direct relevance to their employer’s
needs.  Two possible disadvantages are that the training
experience might be curtailed if the employer’s day-to-day
expectations and/or financial constraints impinge on training
time and opportunities (e.g., access for trainees to external
short courses), and that the training may be narrowly focused
to the current workload and limited on-site training capabili-
ties of the employer.
Regulatory-type toxicologic pathologists will receive
acceptable applied training in either of these two scenarios:
academic residency followed by abbreviated (2-year) on-
the-job apprenticeship or extended (4-year) on-the-job
apprenticeship.  However, a likely benefit of the residency-
oriented option is that pathology trainees will study many
more diagnostic problems and use a larger set of diagnostic
tools relative to those needed for typical regulatory-type tox-
icologic pathology investigations.  Such broad exposure is
an essential part of a toxicologic pathologist’s knowledge
base because many non-toxic etiologies (e.g., infectious and
metabolic diseases) as well as spontaneous background find-
ings can impact the genesis, progression, extent, and perma-
nence of toxicant-induced lesions.  In the authors’
experience, diagnostic principles relevant to interpreting the
significance of complex disease patterns (in which nontoxic
and toxicant-induced lesions are intermingled) are better
understood in laboratory animal species if the principles
were first learned by studying as many animal species as
possible (including companion, domestic, and exotic spe-
cies).  The range of disease entities and animal species
needed to attain wide-ranging appreciation of diagnostic
principles, multiple etiologies, and complex pathophysio-
logic mechanisms is generally much broader in a hospital or
clinical practice setting (i.e., residency) relative to a labora-
tory focused specifically on toxicologic pathology research.
The possession of a formal pathology certification by
regulatory-type toxicologic pathologists is a necessary pre-
requisite in some institutions and geographic regions but is
optional in others.  The utility of holding a pathology quali-
fication is clearly acknowledged by the recent IFSTP pro-
posal to develop a global recognition system6.  Accordingly,
certification in pathology is recommended to tangibly dem-
onstrate that an individual has learned the core knowledge
and applied skills needed for professional practice.  Widely
accepted certification mechanisms used for this purpose
include qualifications specifically for toxicologic pathology
(e.g., CRP/TP, FRCPath/ToxPath, FTA Pathol/Tox Pathol,
FIATP, and JSTP) as well as those for anatomic pathology or
Table 3. International Recommendations for Applied Skills and Tools to be Used in Training Regulatory-
Type Toxicologic Pathologists 
Autopsy / Necropsy — gross dissection, organ weights
Histopathology — assessment of tissue sections processed using:
Routine stains (e.g., hematoxylin and eosin [H&E]) 
Special stains (e.g., Masson’s trichrome, periodic acid-Schiff) 
Immunohistochemistry 
Clinical Pathology — assessment of biological fluids / tissue smears using:
Clinical chemistry 
Coagulation
Hematology 
Urinalysis 
Experimental Design (for relevant pathology-based endpoints)
Regulatory Standards (e.g., Good Laboratory Practices [GLP], conventional study design)
Statistics (for analyzing pathology data sets)
Recommended functions represent a minimum approach.  Additional specialty-specific skills should be
included when appropriate.
Toxicologic pathologists must have classes, laboratory experiences, or appropriate on-the-job practice in
all of these skills and tools relevant to their role.  This list represents the minimum practices that must be
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clinical pathology (e.g., ACVP, DESV-APV, ECVP,
ECVCP, FTA klin Lab, JCVP, and SVTP).  The conventions
for eligibility and the criteria and mechanisms for awarding
these various qualifications vary across regions, but in gen-
eral they use educational and experiential standards that are
similar in the broad sense with those outlined above (Sec-
tions 3 and 4).
5. How much training do regulatory-type toxicologic
pathologists require?
The time and effort required by trainees, teacher(s),
training institutions, and employers to prepare an individual
for a career in regulatory-type toxicologic pathology will
vary somewhat with the chosen approaches to academic
coursework and practical experience.  The proposed outline
of optimal (“best;” Table 4) and realistic (“acceptable;”
Table 5) training practices endeavors to balance these indi-
vidual, institutional, and societal preferences with the abso-
lute requirement that proficiency cannot be attained unless
sufficient exposure over time has been obtained for both the-
oretical knowledge and the applied skills and tools of the
toxicologic pathology trade.
The education of a regulatory-type toxicologic patholo-
gist typically will require a minimum of 9 years of combined
academic coursework and practical training.  This time span
reflects two factors.  First, the number and complexity of
subjects that must be studied to gain the theoretical knowl-
edge necessary for this profession (Table 2) cannot be
attained in less than 5 years of concentrated (i.e., full-time)
study.  Second, acquisition and practice of the applied skills
and tools used in regulatory-type toxicologic pathology can-
not be completed in less than 4 years of applied training.  In
some nations this concentrated practical experience is under-
taken as a 2- to 3-year-long formal veterinary medical resi-
dency (or medical residency, or possibly a graduate degree
program in medical biology emphasizing hands-on, systems-
based research experience in pathology with exposure to
diagnostic and interpretative case work) under the tutelage of
one or ideally several experienced pathologists, followed by
2 or more years of on-the-job training in regulatory-type tox-
icologic pathology working with a team of mentors (toxico-
logic pathologists, toxicologists, and expert technical staff).
In other regions, practical experience is attained entirely via
an intensive on-the-job training program in regulatory-type
toxicologic pathology, lasting at least 4 years, with mentor-
ing by an interdisciplinary team of scientists.  Regardless of
the training institution and approach, the toxicologic pathol-
ogy trainee will spend many hours learning and practicing
essential skills and techniques of pathology (Table 3) such as
sample (tissue and fluid) collection, handling and process-
ing; analytical methods; data interpretation; quality assur-
ance and quality control; and report preparation.  Repeated,
intense, and broad exposure to these topics is more critical
than the number of years spent in training.  Nevertheless,
true proficiency cannot be obtained in less than 9 years of
intensive education in clinical medicine, general pathology,
and regulatory-type toxicologic pathology.
Training vs. Proficiency
The academic coursework and on-the-job experiences
outlined above have been shown by long historical practice
in developed nations to be successful methods for develop-
ing the toxicologic pathology expertise of persons who sup-
Table 4. International Recommendations for Optimal (“Best”) Practices for Training Future Regulatory-Type Toxicologic Pathologists
Years of training
Veterinary Medical
Activities  pathologist  pathologist
Academic Curriculuma   to acquire core knowledge
Basic sciences: biology, biochemistry, chemistry, physics, molecular biology, and statistics 2 2
Clinical sciences: anatomy (gross and microscopic), physiology, biochemistry, microbiology, 
       pathology (anatomic and clinical), pharmacology, and toxicology 3 to 4 3 to 4
Comparative biology: emphasizing comparative aspects among laboratory animal species
       (employed in regulatory type nonclinical toxicology studies) and humans 1 to 2
ACADEMIC SUBTOTAL 5 to 6 6 to 8
Practical Experience  to apply fundamental methods and skills
Apprenticeship: a formal veterinary medical (or medical) residency in pathology, or a formal  
       “on-the-job” program, served under one (or ideally several) experienced toxicologic pathologists 2 to 3 2 to 3
On-the-job training: quasi-independent practice in toxicologic pathology and regulatory guidelines  2 to 3b 2 to 3b
      under the tutelage of one or more experienced mentors (toxicologic pathologists, toxicologists, OR OR 
and technical staff) 4 to 6c 4 to 6c
PRACTICAL SUBTOTAL 4 to 6 4 to 6
TOTAL 9 to 12 10 to 14
a To be undertaken at an accredited institution.  b If preceded by an academic apprenticeship (residency) of 2 or more years.  c If pathology
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port regulatory-type, nonclinical toxicity studies.  That said,
neither acquisition of a particular academic degree nor pos-
session of a recognized pathology certification provide a
guarantee that true proficiency (i.e., competence) has been
achieved, let alone maintained over time.  Proficiency is not
a static or finite entity.  Individuals will not remain proficient
indefinitely in all the core knowledge and practical skills of
any field.  In toxicologic pathology, this gradual regression
of proficiency will reflect both the ever-expanding nature of
the discipline and the tendency for unused abilities to atro-
phy.  In contrast, individuals will not only retain but also
increase their proficiency over time in the core toxicologic
pathology knowledge, skills, and tools that they use rou-
tinely.
Taken together, these concepts indicate that the initial
complex and lengthy training required to educate a regula-
tory-type toxicologic pathologist represents only the start of
a lifelong commitment to professional education.  Individu-
als serving in this role will be expected to expend consider-
able effort on sharpening known skills and learning new
ones throughout their careers.  Thus, an essential aspect of
training regulatory-type toxicologic pathologists will be to
impart a taste for thorough continuing education.
Three mechanisms seem well suited to maintaining and
extending proficiency in regulatory-type toxicologic pathol-
ogists.  The first is habitual attendance at scientific meetings
or short courses (ideally at least one per year).  The second is
constant reading of relevant books and journals in the field.
These two options are powerful as they can be undertaken at
the individual’s convenience.  Therefore, regulatory-type
toxicologic pathologists should be encouraged to log such
activities as a subjective record of their ongoing training
efforts.  The third mechanism is regular participation in
pathology peer review (either as the study pathologist or the
peer review pathologist).  Advantages of peer review as a
training activity are that documentation of the peer review
process will objectively show that an educational exchange
occurred, while the subject of the review will automatically
address practical aspects of toxicologic pathology practice.
The “best practice” for the continuing education of regula-
tory-type toxicologic pathologists will be to liberally incor-
porate all three of these options.
Critique of the International Recommendations
for Future Training Practices
This IFSTP-proposed global framework for training
regulatory-type toxicologic pathologists in the future was
prepared in stages.  The initial drafts were written by the
committee chair, after which the committee members
worked together to produce a polished draft, which was then
submitted to the IFSTP for distribution to its members soci-
eties.  The governing bodies of the IFSTP member societies
either reviewed the polished draft themselves on behalf of
their membership or circulated it to their entire membership.
In all, this final proposal incorporates more than 200 com-
ments (many raised by multiple individuals) from 70 toxico-
logic pathologists (from both anatomic pathology and
clinical pathology specialties) representing 8 of the 10
IFSTP member societies.
Where feasible, these remarks have been included spe-
cifically in the proposal.  However, four other important side
issues were raised that had no place within the proposal.
These topics are addressed here in “question (Q) and answer
(A)” format to further the debate on this proposal.  The order
in which the items are considered reflects the number of
times the issue was raised in the comments on the prior
IFSTP-circulated draft.  The questions (or comments) have
been edited for content and clarity.
Q.  This IFSTP proposal on training practices is identi-
cal to the IFSTP proposal for a global recognition
mechanism6 that was decisively rejected by a vote of the STP
membership7.  Why circulate the same proposal only 6
Table 5. Medical Biology without Clinical Education as an Alternative Means for Training Regulatory-Type Toxicologic Pathologistsa
Activities Years of training
Academic Curriculumb  to acquire core knowledge
Basic sciences: biology, biochemistry, chemistry, physics, molecular biology, and statistics 2
Medical biology: anatomy (gross and microscopic), physiology, biochemistry, microbiology, pathology 5 to 6
     (anatomic and clinical), pharmacology, and toxicology emphasizing comparative aspects among 
      laboratory animal species (employed in regulatory type nonclinical toxicology studies) and humans
ACADEMIC SUBTOTAL 7 to 8
Practical Experience  to apply fundamental methods and skills
On-the-job training: heavily supervised practice in toxicologic pathology and regulatory guidelines 
       under the tutelage of one or more experienced mentors (toxicologic pathologists, toxicologists, and technical staff) 4 to 6
PRACTICAL SUBTOTAL 4 to 6
TOTAL 11 to 14
a Graduate training in medical biology without training in clinical science is not preferred if sufficient numbers of clinically trained
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months later?
A.  The current proposal does not in any way put for-
ward a global mechanism for recognizing regulatory-type
toxicologic pathologists.  This document is intended only to
suggest an internationally accepted framework of rigorous
but flexible practices for educating regulatory-type toxico-
logic pathologists.  The proof of this assertion is evident in
the text of these two proposals: the international recognition
plan6 was designed to provide a point-based scale for mea-
suring a candidate’s past accomplishments, while the
present training practice proposition recommends a broad
course of study to direct a trainee’s future educational
endeavors.  True, the more uniform training practices listed
here could serve as one facet underpinning any future pro-
posal for global recognition system.  However, as noted in
the next question, a more consistent approach to educating
toxicologic pathologists stands to benefit individuals,
employers, and regulatory agencies regardless of whether a
recognition mechanism is implemented in the future.
Q.  Why is a “best practice” framework for training tox-
icologic pathologists needed when (1) most IFSTP member
societies do not have formal educational standards or certifi-
cation processes and (2) no mechanism exists for enforcing
these international training practice recommendations?
A.  This proposal has two purposes.  The first is to pro-
vide more uniformity of training specifically for those toxi-
cologic pathologists who support regulatory-type,
nonclinical toxicity studies.  Increased consistency will
allow employers and regulatory agencies to more easily
compare the educational backgrounds of regulatory-type
toxicologic pathologists who were trained in different geo-
graphic regions.  The second is to offer a defined target—
based on long-established, successful training practices that
have evolved over time in developed nations—at which tox-
icologic pathology educators from emerging nations might
aim their future training efforts.  The rationale is that transfer
of the well-recognized training practices from developed
nations (which have produced many regulatory-type toxico-
logic pathologists who are acknowledged as “qualified” by
regulatory authorities worldwide) is the best means of assur-
ing that toxicologic pathology education in emerging nations
will attain a similar degree of quality, without expending
scarce resources in reinventing already effective training
techniques.  The IFSTP is a reasonable entity for proposing
such recommendations because most pathology training pro-
grams are not focused on regulatory-type toxicologic pathol-
ogy, while the individuals belonging to IFSTP members
societies are well versed in the training needs of individuals
engaged in their profession.
Q.  What will prevent this set of training practice rec-
ommendations from evolving into a global mechanism for
pseudo-certification in toxicologic pathology?
A.  No impediment exists to prevent an entity from
using these training practice recommendations as one basis
for a recognition mechanism (national or global) in the
future.  However, a widely acknowledged core program of
training does not by itself provide a certification method.
Employers and regulatory agencies are well acquainted with
the difference between training (a course of study) and certi-
fication (an assessment that a given body of knowledge,
skills, and tools has been assimilated).  The current proposal
clearly is limited to a recommended course of study, and pro-
vides no method for evaluating whether or not a trainee has
learned it.  Such testing is the responsibility of the training
institutions and the relevant certifying bodies in a given
nation.
Q.  What on-the-job functions will be acceptable train-
ing practices for regulatory-type toxicologic pathologists?
At what point during an “apprenticeship” will an individual
“graduate” from trainee to proficient pathologist?
A.  Suitable training tasks would include the full scope
of activities undertaken by independent pathologists (e.g.,
data generation and interpretation appropriate to their spe-
cialty, as well as data integration and communication via oral
presentations and written pathology reports).  Our recom-
mendation (see Section 5 above) is that on-the-job training in
regulatory-type toxicologic pathology knowledge, skills,
and tools continue for at least 2 years if a trainee has had
prior intensive experience (e.g., a formal academic resi-
dency) in general pathology, and for at least 4 years if the
trainee has had no such prior experience.  The rationale for
this proposal is that trainees who transition from a formal
pathology residency to a toxicologic pathology position have
already obtained a substantial amount of applied pathology
practice.  The main difference between a “pathology trainee”
and a “proficient pathologist” is the degree to which daily
pathology functions must be supervised by one’s instruc-
tor(s).  Common practice permits trainees to immediately
serve as “study pathologists” (i.e., attest to the validity of
their work by signing the final pathology report), but under
the close supervision and careful peer review by a patholo-
gist with long experience in the conduct of regulatory-type
nonclinical studies.  The graduation date will be set by the
employer at whatever time the supervisor chooses to affirm
that the trainee is capable of performing in a self-sufficient
manner.
International Recommendations for Global
Training Practices
The current IFSTP proposal suggests a rigorous but
flexible framework of training practices for the educational
and work-related experiences that should be employed
worldwide when educating future toxicologic pathologists
who engage in regulatory-type, nonclinical toxicology stud-
ies.
Formal Education in Clinical Science and Pathology
as the Optimal Training Option
The optimal pathway (“best practice;” Table 4) for edu-
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duce individuals with the following attributes: 
* Theoretical Knowledge: acquired during 5 or more
years of scientific and clinical education leading to a
degree in veterinary medicine (or medicine). 
* Practical Experience: acquired by at least 4 years of
intensive practice in one of the two following formats:
o Clinically-based residency (2 or more years) followed
by an on-the-job toxicologic pathology “apprentice-
ship” (informal or formal) of 2 years
o On-the-job toxicologic pathology “apprenticeship” of
4 years
The rationale for proposing a clinical education (veteri-
nary medical or medical degree) as a “best practice” is that
pathology is a medical discipline that requires clinical train-
ing.  Because the subjects of regulatory-type, nonclinical
toxicity studies are animals, medical pathologists will clearly
require additional training in animal-related topics such as
species-specific anatomic and physiological variations as
well as spontaneous diseases.  The logic for the two options
for applied post-graduate training are that the knowledge and
skills necessary for general pathology understanding and
specialized toxicologic pathology performance may be
learned in various settings, but since these options do not
overlap completely, enough time must be spent to acquire
familiarity with both categories of pathology practice.
Medical Biology without Clinical Education as an
Alternative Training Pathway
In some geographic regions a number of long-estab-
lished, regulatory-type toxicologic pathologists have medi-
cal biology backgrounds and have been accorded national or
international recognition as proficient practitioners by their
peers, employers, and regulatory agents on the basis of their
many years of professional activity and their successful par-
ticipation in the pathology peer review process (as both
study pathologists and peer review pathologists).  The typi-
cal features of this option (Table 5) are: 
* Theoretical Knowledge: acquired during 7 or more
years of science education leading to a doctoral-level
degree in a relevant discipline of medical biology (e.g.,
pathology, pharmacology, toxicology) in the absence of
formal training in clinical medicine.  Anatomy and
physiology as well as pathology, pharmacology, and
toxicology must be heavily emphasized in such a non-
clinical curriculum, and these subjects must stress com-
parative and integrated (i.e., “whole animal” rather than
limited to cellular / molecular) understanding.
* Practical Experience: acquired through an intensive
on-the-job toxicologic pathology “apprenticeship” last-
ing at least 4 years.  Intensive on-the-job training and
independent study must fill the gaps in education that
will arise when pathology candidates are not classically
educated first as veterinarians or physicians.
If veterinary pathologists and medical pathologists are
available, this training option should be avoided when
designing training programs to educate future generations of
toxicologic pathologists.  The rationale is that (1) the medi-
cal/veterinary medical education and clinical perspective
required for a true understanding of pathology is reduced in
non-clinical programs, and (2) medical biology training may
be focused on cellular and molecular evaluation rather than
the system-based (“whole animal”) skills and tools that are
the stock-in-trade of regulatory-type toxicologic patholo-
gists with a clinically oriented pathology background.  In
particular, training institutions in emerging nations should
not look to this option as their preferred framework for pro-
ducing more regulatory-type toxicologic pathologists.
Further Educational Activities
Regardless of the training pathway, individuals
employed as regulatory-type toxicologic pathologists are
encouraged to acquire a recognized post-graduate pathology
qualification (i.e., certification).  Such documentation pro-
vides tangible evidence that one has understood a core set of
pathology-related knowledge, skills, and tools at a discrete
point in time.
Pathologists trained by all pathways are also encour-
aged (and in some locations required) to commit to a life-
long, self-motivated program of regular continuing
education activities, such as attending a pertinent scientific
meeting or short course, reading professional literature rele-
vant to the role performed on a habitual basis, and participat-
ing frequently in pathology peer review for nonclinical
toxicology studies.  The exact nature of continuing education
may be varied according to individual, institutional, and/or
societal preferences, but a regular program of ongoing study
will remain a necessary training “best practice” for future
toxicologic pathologists.
Conclusions
These international recommendations for global train-
ing practices have been presented to the IFSTP Executive
Committee as well as the governing bodies and/or of all
IFSTP member societies.  The merits of this proposal have
been discussed by these governing bodies, and at their dis-
cretion by the members of their societies.  At the time of pub-
lication, formal endorsements have been conferred by the
leadership of the IFSTP as well as 8 of the 10 IFSTP member
societies (ALATP, BSTP, ESTP, NVT, SFPT, SIPTS, STP,
STP-I).  We anticipate that these practices, if implemented
consistently, will promote more uniform training among reg-
ulatory-type toxicologic pathologists worldwide.  We urge
all the IFSTP member societies to help training programs for
toxicologic pathologists within their nation or region apply
these recommendations, keeping in mind that all acceptable
training programs for future toxicologic pathologists must
seek to assure that high standards of biomedical instruction
are always upheld.
For the time being, currently used gauges of training
quality (e.g., attaining a relevant national or regional certifi-
cation in pathology, the employer’s satisfaction with the
graduate’s on-the-job performance) will likely remain the
metrics of choice for assessing a newly minted toxicologicProposed Training for Future Toxicologic Pathologists 181
pathologist’s proficiency.  In the future, it is conceivable that
a global mechanism to recognize toxicologic pathologists
could be developed, using these “best practice” recommen-
dations as the standard for training individuals to prepare for
recognition.  However, it is equally plausible that consistent
worldwide application of the optimal training practices
advocated here will ensure the initial proficiency of new tox-
icologic pathologists so effectively that implementing an
international recognition mechanism will be unnecessary.
Either way, these “best practices” for training should provide
a rigorous yet flexible way to reliably educate toxicologic
pathologists from both developed and developing nations to
generate, interpret, integrate, and communicate data in regu-
latory-type, nonclinical toxicology studies.
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